BNP Paribas Financial Markets
FBRX icon

BNP Paribas Financial Markets’s Forte Biosciences FBRX Stock Holding History

BNP Paribas Financial Markets’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$346K Buy
16,290
+12,854
+374% +$305K ﹤0.01% 3953
2026
Q1 		$89K Sell
3,436
-12,036
-78% -$347K ﹤0.01% 4430
2025
Q4 		$422K Buy
15,472
+15,464
+193,300% +$271K ﹤0.01% 3662
2025
Q3 		$120 Hold
8
– – ﹤0.01% 5425
2025
Q2 		$103 Hold
8
– – ﹤0.01% 5324
2025
Q1 		$62 Hold
8
– – ﹤0.01% 5283
2024
Q4 		$182 Hold
8
– – ﹤0.01% 5238
2024
Q3 		$45 Buy
+8
New +$82 ﹤0.01% 4092
2020
Q2 		– Sell
-17
Closed -$7.91K – 4327
2020
Q1 		$7.91K Buy
17
+9
+113% +$3.52K ﹤0.01% 4043
2019
Q4 		$1.52K Sell
8
-1
-11% -$227 ﹤0.01% 4221
2019
Q3 		$2.24K Buy
9
+3
+50% +$4.55K ﹤0.01% 4349
2019
Q2 		$15.7K Sell
6
-6
-50% -$17.8K ﹤0.01% 3980
2019
Q1 		$47.3K Buy
+12
New +$46.4K ﹤0.01% 3528
2018
Q4 		– Sell
-2
Closed -$8.61K – 4257
2018
Q3 		$9.2K Hold
2
– – ﹤0.01% 3773
2018
Q2 		$5.51K Sell
2
-7
-78% -$25.6K ﹤0.01% 4058
2018
Q1 		$40.2K Sell
9
-1
-10% -$4.63K ﹤0.01% 3669
2017
Q4 		$37.4K Buy
10
+8
+400% +$31.9K ﹤0.01% 3798
2017
Q3 		$10.2K Hold
2
– – ﹤0.01% 3864
2017
Q2 		$10.6K Buy
+2
New +$11.3K ﹤0.01% 3929

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

BNP Paribas Financial Markets's FBRX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Forte Biosciences (FBRX) stake by 374% in Q2 2026, buying an estimated $305K and bringing the position to 16,290 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #3953.

BNP Paribas Financial Markets first reported a position in FBRX in Q2 2017 and has held it in 19 quarters since. The position peaked at $422K in Q4 2025. 57 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • BNP Paribas Financial Markets held 16,290 shares of Forte Biosciences worth $346K as of Q2 2026.
  • BNP Paribas Financial Markets bought 12,854 Forte Biosciences shares in Q2 2026, an estimated $305K.
  • Forte Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3953 holding.
  • BNP Paribas Financial Markets first reported a position in Forte Biosciences in Q2 2017 and has held it in 19 quarters since.
  • BNP Paribas Financial Markets's Forte Biosciences position peaked at $422K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.